S. J. Warren

Professor

University of Michigan
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. S. J. Warren is an Assistant Professor in the Department of Pathology & Laboratory Medicine at Indiana University School of Medicine, located in Indianapolis, USA. His research areas primarily focus on melanoma, NTRK fusions, and histopathologic features of various tumors. He has contributed to significant studies on metastatic signatures, unique tumor mutations, and the clinical implications of his findings in targeted treatment.

Articles (8)

Microsatellites in melanoma are physically separate from the primary tumor, are hypothesized to arise by lymphovascular invasion similar to other metastases, and have not been previously studied at the molecular level . We compared gene expression in microsatellites with the matched primary melanoma in two patients using spatial transcriptomics. We identified recurrently altered genes in microsatellites contributing to vascular invasion (ITGA4, MCAM), survival in the circulation (CXCL8, PDGFRB, CDH1), vascular exit (ITGB2), survival at metastatic sites (C3, TGBFI), matrix remodeling (MMP9, VCAN, FN1, BGN), and angiogenesis (EMILIN2). Gene set enrichment analysis confirmed a metastatic signature in comparison to genes upregulated and downregulated in distant melanoma metastases, and identified pathway enrichment for NFKB, CDH1, and ZEB1 signaling. Microsatellites exhibited increased host immune responses and four recurrently overexpressed mediators of immune evasion were present (PAEP, GDF15, CD74, HLA-DRA) implying selection pressure from the increased immune response. Seven additional non-recurrent mediators of immune evasion were identified in microsatellites, overexpressed up to 58-fold in microsatellites. PAEP was 275-fold and 25-fold overexpressed, respectively, in microsatellites in two cases. We studied PAEP protein expression by immunohistochemistry in a larger group of 12 and found overexpression in microsatellites in five of 12 patients. PAEP was detected by immunohistochemistry in a microsatellite and also in a subclone within its primary, raising the possibility that the immunostain identifies the subclone in the primary responsible for the microsatellite. These preliminary findings suggest that melanoma microsatellites are true metastases at the level of gene expression, accounting for the sharply increased risk of disease progression in patients with microsatellites.

Year:

2025

Xanthogranuloma is the most common category of histiocytic neoplasia, with a range of clinical behaviors from solitary cutaneous lesions to multiple cutaneous lesions and less frequent cases with evolution to disseminated disease. Solitary lesions make up 78% to 81% of total cases. We encountered 2 consecutive index patients with solitary cutaneous xanthogranuloma with NTRK overexpression by immunostaining and confirmed the presence of an NTRK1 fusion with both RNA and DNA sequencing. We screened 55 additional patients by pan-TRK immunostain, and found that 26 of 48 (54%) with solitary xanthogranulomas had TRK overexpression, whereas 0 of 7 (0%) multifocal or disseminated xanthogranulomas had TRK overexpression. We sequenced a subset of 23 patients with solitary xanthogranuloma. In all 16 patients with a positive pan-TRK immunostain, we confirmed the presence of an NTRK1 fusion using RNA and DNA sequencing. In all 7 patients that were negative by immunostain we identified no NTRK fusion by sequencing. All patients with a fusion identified by sequencing had overexpression of the NTRK1 RNA transcript relative to wild-type tumors with a mean 58-fold increase over wild-type tumors ( P =8.77e-15). Further, all cases with fusions had a loss of the extracellular portion of NTRK1 , and fusion partners were limited to TPM3, PRDX1, IRF2BP2, LRRIP1 , and SQSTM1 . DNA sequencing identified additional recurrent loss of function mutations in DNA methylation genes DNMT3A, KDM5D , and SETD2, as well as the MTOR-PI3K pathway gene FLCN . Recurrent copy number gains were detected in MTOR-PI3K pathway genes PIK3CG , IL10Ra , as well as transcriptional regulator PAX8 . The frequency of NTRK1 fusions appears markedly higher in solitary compared with multifocal and disseminated xanthogranuloma (54% vs. 0%). The reduced proportion of NTRK1 fusions in disseminated cases relative to solitary cases suggests that NTRK1 fusions are less efficient than MAP kinase pathway point mutations at driving tumor evolution towards disseminated disease. As NTRK1 fusions are uncommon in other histiocytoses, pan-TRK immunostain may have utility to confirm the diagnosis of xanthogranuloma in a histiocytic lineage tumor and to screen for low-risk xanthogranuloma.

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2020

Year:

2020

Collaborators (2)

Ahmed Alomari

Assistant Professor and Dermatopathologist

Indiana University School of Medicine

UNITED STATES
View details

Matthew Kuhar

Indiana University Bloomington

UNITED STATES
View details